Trials / Conditions / Locally Advanced Rectal Adenocarcinoma

Locally Advanced Rectal Adenocarcinoma

12 registered clinical trials studyying Locally Advanced Rectal Adenocarcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	ctDNA-Informed Management of Early-Stage Rectal Cancer NCT07209215	University of California, Davis	Phase 2
Not Yet Recruiting	Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old NCT07118800	UNICANCER	Phase 3
Not Yet Recruiting	Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer NCT07200141	Peking Union Medical College Hospital	Phase 2
Recruiting	Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE NCT06834126	City of Hope Medical Center	Phase 1
Recruiting	A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma NCT06843434	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Pre NCT06108596	The First Affiliated Hospital with Nanjing Medical University	Phase 2
Recruiting	A Study of Tucatinib and Trastuzumab in People With Rectal Cancer NCT05672524	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer NCT04751370	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer NCT04130854	University of Texas Southwestern Medical Center	Phase 2
Terminated	Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally NCT03300544	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer NCT02874885	M.D. Anderson Cancer Center	—
Unknown	XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanc NCT00557713	Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials	Phase 2